Fight The Frown Lines While Avoiding The Overdone Look
Dysport® is an injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults between the ages of 18-65. With Dysport®, it’s just the frown lines that are minimized, not your expressions.
And because Dysport® delivers the natural-looking results people want, 97% of users say they’d do it again. Additionally, Dysport® is approved in 69 countries and has 25 years of clinical experience worldwide
Important Product Information
Here are some answers to the questions we receive the most about our services. If we missed anything, please do not hesitate to contact us. We’ll be happy to help.
Where Can Dysport® Be Used?
Dysport® is FDA indicated to be used for frown lines between the eyebrows. Dysport can also be used off-label to treat many other facial areas such as forehead, around the eyes, around-the mouth and chin.
What Are Possible Side Effects?
The most common side effects are nose and throat irritation, headache, injection site pain, injection site skin reaction, upper respiratory tract infection, eyelid swelling, eyelid drooping, sinus inflammation, and nausea.
How Long Is It Indicated?
The majority of users see improvements in just 2 to 3 days after treatment⁴ however may take up to 14 days for full results. Dysport may Help the look of lines and wrinkles for up to 4 months.
What Are The Contraindications?
Do not take Dysport® if you…
- Are allergic to Dysport® or any of the ingredients in Dysport®
- Are allergic to cow’s milk protein (this is not the same as lactose intolerance).
- Had an allergic reaction to any other botulinum toxin product, such as Myobloc® (rimabotulinumtoxinB), Botox®(onabotulinumtoxinA) or Xeomin® (incobotulinumtoxinA)
- Have a skin infection at the planned injection site
Does The Procedure Hurt?
We strive to make your experience as comfortable as possible. We use various techniques which help minimize the client’s discomfort.
For more information about this product please visit Dysport’s® website.
References
- Molina B, Grangier Y, Mole B, et al. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study. J Eur Acad Dermatol Venereol. 2015;29(7):1382-8. doi:10.1111/djv.12881. Epub 2014 Dec 12.
- Data on file. Ipsen World-Wide Marketing Authorisation Status. Fort Worth, TX: Galderma Laboratories, L.P., February 2017.
- Medicines and Healthcare products Regulatory Agency (MHRA). Botulinum Toxin Type A Powder For Solution For Injection (Clostridium botulinum toxin type A – Haemagglutinin complex). http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con108644.pdf . Accessed May 11, 2015.
- Data on file. MA-Y-97-52120-719 (GL-1) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.
- Data on file. MA-Y-97-52120-718 (GL-3) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.
- Data on file. MA-Y-97-52120-085 (GL-2) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.
- Dysport for Injection Package Insert. Fort Worth, TX: Galderma Laboratories, L.P.; September 2017.